Baseline level of circulating endothelial progenitors predicts progression-free survival and overall survival in advanced hepatocellular carcinoma patients treated with sorafenib plus metronomic chemotherapy

被引：0
|
作者：
Shao, Yu-Yun
Lin, Zhong-Zhe
Chen, Te-Jung
Chang, Dwan-Ying
Hsu, Chiun
Shen, Ying-Chun
Hsu, Chih-Hung
Cheng, Ann-Lii
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] TTY Bio Pharm Ltd Co, Taipei, Taiwan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
690
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Effects of combined sintilimab and chemotherapy on progression-free survival and overall survival in osteosarcoma patients with metastasis
    Li, Fan
    Zhang, De-bao
    Ma, Yue
    Song, Yang
    Duan, Xian-liang
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (04) : 648 - 651
  • [32] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [33] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [34] Cardiovascular Comorbidities for Prediction of Progression-Free Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Sorafenib
    Szmit, Sebastian
    Zaborowska, Magdalena
    Wasko-Grabowska, Anna
    Zolnierek, Jakub
    Nurzynski, Pawel
    Filipiak, Krzysztof J.
    Opolski, Grzegorz
    Szczylik, Cezary
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (06): : 468 - 476
  • [35] Early alpha-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Lee, Sangheun
    Kim, Beom Kyung
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    [J]. JOURNAL OF HEPATOCELLULAR CARCINOMA, 2015, 2 : 39 - +
  • [36] Association of Progression-Free Survival With Overall Survival in Patients With Neuroendocrine Tumor Treated With Somatostatin Analogs
    Ter-Minassian, Monica
    Brooks, Nichole V.
    Brais, Lauren K.
    Chan, Jennifer A.
    Christiani, David C.
    Lin, Xihong
    Gabriel, Sylvie
    Dinet, Jerome
    Kulke, Matthew H.
    [J]. PANCREAS, 2016, 45 (03) : 483 - 483
  • [37] Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
    Ohki, Takamasa
    Sato, Koki
    Kondo, Mayuko
    Goto, Eriko
    Sato, Takahisa
    Kondo, Yuji
    Akamatsu, Masatoshi
    Sato, Shinpei
    Yoshida, Hideo
    Koike, Yukihiro
    Obi, Shuntaro
    [J]. DRUGS-REAL WORLD OUTCOMES, 2020, 7 (02) : 141 - 149
  • [38] Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
    Takamasa Ohki
    Koki Sato
    Mayuko Kondo
    Eriko Goto
    Takahisa Sato
    Yuji Kondo
    Masatoshi Akamatsu
    Shinpei Sato
    Hideo Yoshida
    Yukihiro Koike
    Shuntaro Obi
    [J]. Drugs - Real World Outcomes, 2020, 7 : 141 - 149
  • [39] Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma
    Cheng, SJ
    Freeman, RB
    Wong, JB
    [J]. LIVER TRANSPLANTATION, 2002, 8 (04) : 323 - 328
  • [40] Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Halabi, Susan
    Rini, Brian
    Escudier, Bernard
    Stadler, Walter M.
    Small, Eric J.
    [J]. CANCER, 2014, 120 (01) : 52 - 60
12345